Capsule filler
MG America offers the new FlexaLAB Capsule Filler, which can produce up to 3000 capsules/hr. Specifically designed for R&D labs, clinical trials, small batch outputs and special productions, Flexa-LAB can function at continuous or intermittent motion. Multiple dosing units can be utilized simultaneously, enabling the FlexaLAB to manufacture capsules with product combinations.
MG America, Fairfield, NJ
• www.mgamerica.com • tel. 973.808.8185
INTERPHEX Booth # 2253
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.